Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U. Höglinger, Keith A. Josephs, Anthony E. Lang et al.|Movement Disorders|2017Cited by 2.3k
Which ante mortem clinical features predict progressive supranuclear palsy pathology?Gesine Respondek, Carolin Kurz, Thomas Arzberger et al.|Movement Disorders|2017Cited by 163
α-Synuclein in Parkinson’s disease: causal or bystander?Peter Riederer, Camelia‐Maria Monoranu, Daniela Berg et al.|Journal of Neural Transmission|2019Cited by 114